Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry		 vs
history
Cash-to-Debt 0.06
VWR's Cash-to-Debt is ranked lower than
96% of the 261 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.52 vs. VWR: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
VWR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.06 Max: 0.12
Current: 0.06
0.05
0.12
Equity-to-Asset 0.32
VWR's Equity-to-Asset is ranked lower than
85% of the 239 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.61 vs. VWR: 0.32 )
Ranked among companies with meaningful Equity-to-Asset only.
VWR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.08  Med: 0.27 Max: 0.32
Current: 0.32
0.08
0.32
Debt-to-Equity 1.27
VWR's Debt-to-Equity is ranked lower than
87% of the 164 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.36 vs. VWR: 1.27 )
Ranked among companies with meaningful Debt-to-Equity only.
VWR' s Debt-to-Equity Range Over the Past 10 Years
Min: 1.27  Med: 1.57 Max: 7.75
Current: 1.27
1.27
7.75
Debt-to-EBITDA 4.74
VWR's Debt-to-EBITDA is ranked lower than
84% of the 116 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.77 vs. VWR: 4.74 )
Ranked among companies with meaningful Debt-to-EBITDA only.
VWR' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.94  Med: 4.54 Max: 9.27
Current: 4.74
3.94
9.27
Interest Coverage 3.90
VWR's Interest Coverage is ranked lower than
85% of the 163 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 76.01 vs. VWR: 3.90 )
Ranked among companies with meaningful Interest Coverage only.
VWR' s Interest Coverage Range Over the Past 10 Years
Min: 1.25  Med: 1.62 Max: 3.96
Current: 3.9
1.25
3.96
Piotroski F-Score: 6
Altman Z-Score: 1.90
Beneish M-Score: -2.51
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry		 vs
history
Operating Margin % 6.75
VWR's Operating Margin % is ranked higher than
61% of the 242 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -0.59 vs. VWR: 6.75 )
Ranked among companies with meaningful Operating Margin % only.
VWR' s Operating Margin % Range Over the Past 10 Years
Min: 6.07  Med: 6.69 Max: 7.41
Current: 6.75
6.07
7.41
Net Margin % 3.27
VWR's Net Margin % is ranked higher than
61% of the 241 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -2.48 vs. VWR: 3.27 )
Ranked among companies with meaningful Net Margin % only.
VWR' s Net Margin % Range Over the Past 10 Years
Min: 0.09  Med: 2.34 Max: 3.57
Current: 3.27
0.09
3.57
ROE % 9.62
VWR's ROE % is ranked higher than
69% of the 242 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -6.75 vs. VWR: 9.62 )
Ranked among companies with meaningful ROE % only.
VWR' s ROE % Range Over the Past 10 Years
Min: -20.54  Med: 10.47 Max: 13.96
Current: 9.62
-20.54
13.96
ROA % 2.93
VWR's ROA % is ranked higher than
65% of the 262 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -4.54 vs. VWR: 2.93 )
Ranked among companies with meaningful ROA % only.
VWR' s ROA % Range Over the Past 10 Years
Min: 0.14  Med: 3 Max: 3.16
Current: 2.93
0.14
3.16
ROC (Joel Greenblatt) % 41.91
VWR's ROC (Joel Greenblatt) % is ranked higher than
81% of the 259 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -9.57 vs. VWR: 41.91 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
VWR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 37.56  Med: 57.31 Max: 73.39
Current: 41.91
37.56
73.39
3-Year Revenue Growth Rate -90.60
VWR's 3-Year Revenue Growth Rate is ranked lower than
97% of the 182 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 4.80 vs. VWR: -90.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
VWR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -90.7 Max: -90.6
Current: -90.6
3-Year EBITDA Growth Rate -90.10
VWR's 3-Year EBITDA Growth Rate is ranked lower than
97% of the 178 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 10.10 vs. VWR: -90.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
VWR' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -90.1 Max: -89.9
Current: -90.1
GuruFocus has detected 3 Warning Signs with VWR Corp VWR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» VWR's 30-Y Financials

Financials (Next Earnings Date: 2018-05-04)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income
» VWR's Warning Signs

Warning Signs

Subscribe to see Warning Signs. .

Start your free trial

» Details

Guru Trades
Q1 2017

VWR Guru Trades in Q1 2017

Joel Greenblatt 46,582 sh (+120.69%)
Robert Olstein 506,824 sh (+17.22%)
Jim Simons 186,000 sh (-13.25%)
Paul Tudor Jones 11,611 sh (-27.17%)
Columbia Wanger 1,390,129 sh (-41.92%)
» More
Q2 2017

VWR Guru Trades in Q2 2017

Mario Gabelli 62,600 sh (New)
David Dreman 1,196 sh (New)
John Paulson 2,675,200 sh (New)
Jim Simons 836,700 sh (+349.84%)
Paul Tudor Jones Sold Out
Columbia Wanger Sold Out
Joel Greenblatt Sold Out
Robert Olstein 451,124 sh (-10.99%)
» More
Q3 2017

VWR Guru Trades in Q3 2017

Caxton Associates 13,800 sh (New)
Mario Gabelli 116,819 sh (+86.61%)
David Dreman 1,196 sh (unchged)
John Paulson Sold Out
Jim Simons 829,200 sh (-0.90%)
Robert Olstein 364,648 sh (-19.17%)
» More
Q4 2017

VWR Guru Trades in Q4 2017

Caxton Associates Sold Out
Robert Olstein Sold Out
Mario Gabelli Sold Out
David Dreman Sold Out
Jim Simons Sold Out
» More
» Details

Insider Trades

Financial Reports

Latest Guru Trades with VWR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Dreman 2017-12-31 Sold Out 0.02%$33.06 - $33.25 $ 33.250%0
Robert Olstein 2017-12-31 Sold Out 1.56%$33.06 - $33.25 $ 33.250%0
Mario Gabelli 2017-12-31 Sold Out 0.02%$33.06 - $33.25 $ 33.250%0
Robert Olstein 2017-09-30 Reduce -19.17%0.36%$32.95 - $33.18 $ 33.251%364,648
Mario Gabelli 2017-09-30 Add 86.61%0.01%$32.95 - $33.18 $ 33.251%116,819
John Paulson 2017-09-30 Sold Out 1.2%$32.95 - $33.18 $ 33.251%0
John Paulson 2017-06-30 New Buy1.2%$27.23 - $34.05 $ 33.257%2,675,200
Robert Olstein 2017-06-30 Reduce -10.99%0.2%$27.23 - $34.05 $ 33.257%451,124
Mario Gabelli 2017-06-30 New Buy0.01%$27.23 - $34.05 $ 33.257%62,600
David Dreman 2017-06-30 New Buy0.02%$27.23 - $34.05 $ 33.257%1,196
Joel Greenblatt 2017-06-30 Sold Out 0.02%$27.23 - $34.05 $ 33.257%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research    NAICS: 621511    SIC: 8099
Compare:NAS:NEOG, NAS:BRKR, MIL:DIA, NAS:SYNH, NYSE:CRL, NAS:EXAS, NAS:PRAH, XTER:AFX, SHSE:603658, NAS:FMI, NAS:DXCM, BSP:DASA3, BSP:FLRY3, NAS:ICLR, TSE:4544, SHSE:603882, SZSE:300463, NAS:MYGN, SZSE:300244, NAS:QDEL » details
Traded in other countries:VW1.Germany,
Headquarter Location:USA
VWR Corp is a distributor of laboratory products mainly in the United States and to a lesser extent in Europe. Its products include chemicals, reagents, consumables, durable products, and scientific instruments.

VWR Corp operates in the healthcare sector based in the United States. It primarily offers laboratory products mainly in the American market, while distributing a minor share abroad. It provides a suite of products such as chemicals, reagents, consumables, durable products and scientific equipment and instruments to customers in the life science, general research and applied markets, including the biopharma, agricultural, chemical, environmental, food and beverage, healthcare, microelectronic, and petrochemical industries.

Top Ranked Articles about VWR Corp

Robert Olstein's Largest Sales of the 4th Quarter He closed several positions like VWR, Convergys and Mattel
February 9, 2018
The chairman and chief investment officer of the Olstein Financial Alert Fund, Robert Olstein (Trades, Portfolio), sold shares in the following stocks during the fourth quarter. Read more...
Avantor® Completes Acquisition of VWR
November 21, 2017
Read more...
Investor Expectations to Drive Momentum within VWR, The Michaels Companies, KalVista Pharmaceuticals, PACCAR, Jaguar Health, and CPI Card Group – Discovering Underlying Factors of Influence
November 1, 2017
Read more...
Zymo Research and VWR Team Up in Strategic Supplier Partnership
October 31, 2017
Read more...
VWR and Scientist.com Collaborate to Create an End-to-End Online Research Solution
October 17, 2017
Read more...
VWR Sales Team Helps Raise $12,000 for Duke Children's
October 3, 2017
Read more...
VWR Announces New Kitting Center in Czech Republic to Support Customers Globally
September 25, 2017
Read more...
VWR's Jim Rubbo Recognized by The M&A Advisor
September 21, 2017
Read more...
VWR Showcases New 125,000 Square Foot Regional Distribution Center
August 22, 2017
Read more...
The VWR Foundation Approves Over $140,000 in Grants
August 9, 2017
Read more...

Ratios

vs
industry		 vs
history
PE Ratio 29.17
VWR's PE Ratio is ranked higher than
62% of the 113 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 35.00 vs. VWR: 29.17 )
Ranked among companies with meaningful PE Ratio only.
VWR' s PE Ratio Range Over the Past 10 Years
Min: 19.63  Med: 26.78 Max: 72.26
Current: 29.17
19.63
72.26
PE Ratio without NRI 29.17
VWR's PE Ratio without NRI is ranked higher than
63% of the 113 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 35.56 vs. VWR: 29.17 )
Ranked among companies with meaningful PE Ratio without NRI only.
VWR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 19.63  Med: 26.78 Max: 72.46
Current: 29.17
19.63
72.46
Price-to-Owner-Earnings 20.44
VWR's Price-to-Owner-Earnings is ranked higher than
78% of the 76 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 36.75 vs. VWR: 20.44 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
VWR' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 20.33  Med: 23.94 Max: 27.64
Current: 20.44
20.33
27.64
PB Ratio 2.56
VWR's PB Ratio is ranked higher than
73% of the 245 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 4.02 vs. VWR: 2.56 )
Ranked among companies with meaningful PB Ratio only.
VWR' s PB Ratio Range Over the Past 10 Years
Min: 2.2  Med: 2.56 Max: 2.94
Current: 2.56
2.2
2.94
PS Ratio 0.95
VWR's PS Ratio is ranked higher than
90% of the 230 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.81 vs. VWR: 0.95 )
Ranked among companies with meaningful PS Ratio only.
VWR' s PS Ratio Range Over the Past 10 Years
Min: 0.69  Med: 0.81 Max: 0.96
Current: 0.95
0.69
0.96
Price-to-Free-Cash-Flow 19.58
VWR's Price-to-Free-Cash-Flow is ranked higher than
70% of the 80 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 29.22 vs. VWR: 19.58 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
VWR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.27  Med: 18.59 Max: 27.86
Current: 19.58
0.27
27.86
Price-to-Operating-Cash-Flow 15.60
VWR's Price-to-Operating-Cash-Flow is ranked higher than
70% of the 97 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 19.94 vs. VWR: 15.60 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
VWR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.15  Med: 14.76 Max: 21.7
Current: 15.6
0.15
21.7
EV-to-EBIT 20.30
VWR's EV-to-EBIT is ranked higher than
64% of the 118 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 25.06 vs. VWR: 20.30 )
Ranked among companies with meaningful EV-to-EBIT only.
VWR' s EV-to-EBIT Range Over the Past 10 Years
Min: 11  Med: 16.6 Max: 21.3
Current: 20.3
11
21.3
EV-to-EBITDA 14.01
VWR's EV-to-EBITDA is ranked higher than
70% of the 132 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 20.75 vs. VWR: 14.01 )
Ranked among companies with meaningful EV-to-EBITDA only.
VWR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.7  Med: 11.9 Max: 14.6
Current: 14.01
8.7
14.6
EV-to-Revenue 1.39
VWR's EV-to-Revenue is ranked higher than
86% of the 242 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 4.24 vs. VWR: 1.39 )
Ranked among companies with meaningful EV-to-Revenue only.
VWR' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.1  Med: 1.2 Max: 1.4
Current: 1.39
1.1
1.4
Current Ratio 1.25
VWR's Current Ratio is ranked lower than
83% of the 250 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.58 vs. VWR: 1.25 )
Ranked among companies with meaningful Current Ratio only.
VWR' s Current Ratio Range Over the Past 10 Years
Min: 1.18  Med: 1.51 Max: 1.82
Current: 1.25
1.18
1.82
Quick Ratio 0.79
VWR's Quick Ratio is ranked lower than
90% of the 250 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.14 vs. VWR: 0.79 )
Ranked among companies with meaningful Quick Ratio only.
VWR' s Quick Ratio Range Over the Past 10 Years
Min: 0.76  Med: 1.01 Max: 1.22
Current: 0.79
0.76
1.22
Days Inventory 53.43
VWR's Days Inventory is ranked higher than
61% of the 204 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 79.76 vs. VWR: 53.43 )
Ranked among companies with meaningful Days Inventory only.
VWR' s Days Inventory Range Over the Past 10 Years
Min: 20.33  Med: 44.26 Max: 53.43
Current: 53.43
20.33
53.43
Days Sales Outstanding 54.37
VWR's Days Sales Outstanding is ranked higher than
65% of the 204 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 67.51 vs. VWR: 54.37 )
Ranked among companies with meaningful Days Sales Outstanding only.
VWR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.68  Med: 49.29 Max: 54.37
Current: 54.37
48.68
54.37
Days Payable 56.05
VWR's Days Payable is ranked lower than
57% of the 187 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 63.34 vs. VWR: 56.05 )
Ranked among companies with meaningful Days Payable only.
VWR' s Days Payable Range Over the Past 10 Years
Min: 50.82  Med: 54.33 Max: 56.46
Current: 56.05
50.82
56.46

Buy Back

vs
industry		 vs
history
3-Year Average Share Buyback Ratio -995.90
VWR's 3-Year Average Share Buyback Ratio is ranked lower than
99% of the 180 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -7.90 vs. VWR: -995.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
VWR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -995.9  Med: -995.3 Max: 0
Current: -995.9
-995.9
0

Valuation & Return

vs
industry		 vs
history
Price-to-Median-PS-Value 1.17
VWR's Price-to-Median-PS-Value is ranked lower than
59% of the 193 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.01 vs. VWR: 1.17 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
VWR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.9  Med: 1.01 Max: 1.18
Current: 1.17
0.9
1.18
Earnings Yield (Greenblatt) % 4.93
VWR's Earnings Yield (Greenblatt) % is ranked higher than
84% of the 265 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -0.98 vs. VWR: 4.93 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
VWR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.7  Med: 6 Max: 9.1
Current: 4.93
4.7
9.1

More Statistics

Revenue (TTM) (Mil) $4,639.90
EPS (TTM) $ 1.14
52-Week Range $24.42 - 37.25
Shares Outstanding (Mil)131.87

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 4,707 4,863 4,970
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 1.93 1.98 2.08
EPS without NRI ($) 1.93 1.98 2.08
EPS Growth Rate
(Future 3Y To 5Y Estimate)		 N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

» More Articles for VWR

Headlines

Articles On GuruFocus.com
Robert Olstein's Largest Sales of the 4th Quarter Feb 09 2018 
Avantor® Completes Acquisition of VWR Nov 21 2017 
Investor Expectations to Drive Momentum within VWR, The Michaels Companies, KalVista Pharmaceuticals Nov 01 2017 
Zymo Research and VWR Team Up in Strategic Supplier Partnership Oct 31 2017 
VWR and Scientist.com Collaborate to Create an End-to-End Online Research Solution Oct 17 2017 
VWR Sales Team Helps Raise $12,000 for Duke Children's Oct 03 2017 
VWR Announces New Kitting Center in Czech Republic to Support Customers Globally Sep 25 2017 
VWR's Jim Rubbo Recognized by The M&A Advisor Sep 21 2017 
VWR Showcases New 125,000 Square Foot Regional Distribution Center Aug 22 2017 
The VWR Foundation Approves Over $140,000 in Grants Aug 09 2017 

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}